Insilico Medicine Hong Kong Limited
Clinical trials sponsored by Insilico Medicine Hong Kong Limited, explained in plain language.
-
New cancer pill enters first human tests
Disease control Not yet recruitingThis early-phase trial tests an experimental drug called ISM5939, taken as a pill, in people with advanced or metastatic solid tumors that have not responded to standard treatments. The study will first test the drug alone, then in combination with chemotherapy (cisplatin or doce…
Phase: PHASE1 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
AI-Designed drug targets scarred lungs in major trial
Disease control Not yet recruitingThis phase 3 trial tests whether the oral drug rentosertib (INS018_055) can slow lung function decline in adults with idiopathic pulmonary fibrosis (IPF), a progressive lung disease. About 320 participants will receive either rentosertib or a placebo daily for 52 weeks. The main …
Phase: PHASE3 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC